The role of miR-139-5p in radioiodine-resistant thyroid cancer

PURPOSE: Radioiodine I-131 (RAI) is the therapy of choice for differentiated thyroid cancer (DTC). Between 5% and 15% of DTC patients become RAI refractory, due to the loss of expression/function of iodide metabolism components, especially the Na/I symporter (NIS). We searched for a miRNA profile as...

Descripción completa

Detalles Bibliográficos
Autores principales: Pecce, V., Sponziello, M., Verrienti, A., Grani, G., Abballe, L., Bini, S., Annunziata, S., Perotti, G., Salvatori, M., Zagaria, L., Maggisano, V., Russo, D., Filetti, S., Durante, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514163/
https://www.ncbi.nlm.nih.gov/pubmed/36933170
http://dx.doi.org/10.1007/s40618-023-02059-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514163/
https://www.ncbi.nlm.nih.gov/pubmed/36933170
http://dx.doi.org/10.1007/s40618-023-02059-7

Ejemplares similares